Evofem Announces Fifth Amendment to Notes Purchase Agreement
Evofem Biosciences, Inc. amended its securities purchase agreement with Adjuvant Global on Oct. 9, extending the financial terms under which convertible promissory notes are issued.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed